| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +16% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -23% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,437.20 +21.10 (0.87%) | 18,365.19 | 27.09 | 5.45 | ||
PfizerPFIZER | ₹3,876.00 +41.30 (1.08%) | 17,532.36 | 23.85 | 4.17 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,399.00 +31.00 (0.49%) | 15,912.75 | 93.81 | 18.23 | ||
Natco PharmaNATCOPHARM | ₹804.90 +16.15 (2.05%) | 15,489.42 | 13.53 | 1.48 |